Tygh Capital Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCA
JWA
AIC
BFA
MCM
WA
MIP
TCM
Tygh Capital Management's IRMD Position: Q2 2016 in Review
Tygh Capital Management sold out of iRadimed (IRMD) in Q2 2016, closing a stake of 69,045 shares — an estimated $1.32M sold.
Tygh Capital Management first reported a position in IRMD in Q4 2015 and held it in 2 quarters. The position peaked at $3.87M in Q4 2015. 60 funds tracked by Wall St. Rank hold IRMD as of Q2 2016.
- Tygh Capital Management reported no remaining iRadimed position as of Q2 2016 after selling out during the quarter.
- Tygh Capital Management sold 69,045 iRadimed shares in Q2 2016, an estimated $1.32M.
- Tygh Capital Management first reported a position in iRadimed in Q4 2015 and held it in 2 quarters.
- Tygh Capital Management's iRadimed position peaked at $3.87M in Q4 2015.
- 60 funds tracked by Wall St. Rank held iRadimed as of Q2 2016.
Based on Tygh Capital Management's 13F filing for Q2 2016, filed 4 Aug 2016.